Last Updated: May 31, 2026

Suppliers and packagers for CLARITIN HIVES RELIEF


✉ Email this page to a colleague

« Back to Dashboard


CLARITIN HIVES RELIEF

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bayer Healthcare Llc CLARITIN HIVES RELIEF loratadine SYRUP;ORAL 020641 NDA Bayer HealthCare LLC. 11523-0101-1 1 BOTTLE in 1 CARTON (11523-0101-1) / 30 mL in 1 BOTTLE 2024-05-22
Bayer Healthcare Llc CLARITIN HIVES RELIEF loratadine SYRUP;ORAL 020641 NDA Bayer HealthCare LLC. 11523-0101-2 1 BOTTLE in 1 CARTON (11523-0101-2) / 80 mL in 1 BOTTLE 2024-05-22
Bayer Healthcare Llc CLARITIN HIVES RELIEF loratadine SYRUP;ORAL 020641 NDA Bayer HealthCare LLC. 11523-0101-3 1 BOTTLE in 1 CARTON (11523-0101-3) / 240 mL in 1 BOTTLE 2024-05-22
Bayer Healthcare Llc CLARITIN HIVES RELIEF loratadine SYRUP;ORAL 020641 NDA Bayer HealthCare LLC. 11523-4360-1 1 BOTTLE in 1 CARTON (11523-4360-1) / 60 mL in 1 BOTTLE 2015-05-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for CLARITIN HIVES RELIEF (Loratadine)

Last updated: April 26, 2026

What product is CLARITIN HIVES RELIEF?

CLARITIN HIVES RELIEF is a brand of loratadine (an oral antihistamine). In the U.S., the product is marketed under the Clariitin brand by Bayer and formulated as solid-dose oral therapy (tablet and similar strengths depending on market and packaging).

Who supplies the drug (manufacturer of record / brand owner)?

  • Brand owner / marketer: Bayer (Clariitin brand).
  • Primary supplier for the U.S. market: Bayer’s commercial supply chain for loratadine finished dosage forms under the Clariitin brand.

How does the supply chain typically split for this product?

CLARITIN HIVES RELIEF is a finished pharmaceutical dosage product, so the supply chain usually splits into:

  • API supply (loratadine): manufacturer of the active ingredient.
  • Finished dose manufacturing: contract or in-house manufacturer producing tablets/capsules/similar dosage.
  • Brand distribution: Bayer distribution to wholesalers and retail channels.

Which suppliers make or source loratadine (API) for branded antihistamines?

For loratadine-based products, the market typically includes:

  • Generic and API makers in China/India supplying commercial loratadine API to brand and generic finished-dose manufacturers.
  • Finished-dose manufacturers operating under commercial supply agreements, producing tablets using sourced API.

However, identifying the specific named suppliers for CLARITIN HIVES RELIEF in a given market (U.S. package, batch, or NDC) requires a product-specific manufacturer listing.

What do you need to identify the exact named suppliers for this specific brand SKU?

The authoritative supplier names are typically found on:

  • FDA labeling (package insert or prescribing information) and NDC/labeler data
  • FDA Orange Book entries tied to the exact strength and dosage form (labeler, applicant, listed patents and approvals)
  • Supply chain statements in the labeling (manufacturing sites, packaged by, distributed by)

Which public datasets typically contain “supplier” for CLARITIN HIVES RELIEF?

  • FDA Orange Book: shows the applicant/labeler for each approved product (product-specific).
  • FDA NDC Directory: maps the labeler (and sometimes manufacturing details) to product identifiers.
  • FDA SPL (Structured Product Labeling): contains “manufactured for” / “distributed by” statements.

Key supplier conclusion for decision-making

With the information provided, the only supplier-level statement that can be made accurately at the brand level is:

  • Bayer is the brand owner/marketer for CLARITIN HIVES RELIEF (loratadine).

Key Takeaways

  • CLARITIN HIVES RELIEF contains loratadine.
  • Bayer is the brand owner/marketer for the Clariitin line in the U.S.
  • Named API and finished-dose suppliers for the exact SKU are determined by product-specific FDA labeler/NDC/Orange Book listings, which cannot be conclusively identified from the product name alone.

FAQs

  1. Is CLARITIN HIVES RELIEF loratadine?
    Yes. CLARITIN HIVES RELIEF is a loratadine antihistamine product.

  2. Who owns the CLARITIN brand?
    Bayer is the brand owner/marketer for Clariitin.

  3. Are the API and tablet suppliers the same entity?
    Usually not. API is often sourced from specialized API manufacturers, while tablets are produced by finished-dose manufacturers under supply agreements.

  4. Where can you find the exact manufacturing supplier names for a specific CLARITIN package?
    The exact “manufactured for / distributed by / packaged by” details come from the product’s FDA listing and package labeling tied to a specific NDC/strength/dosage form.

  5. Does the supplier change by strength or dosage form?
    Yes. Different strengths and dosage forms can have different manufacturers and labeler records.

References

[1] U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/
[2] U.S. Food and Drug Administration. NDC Directory. https://www.fda.gov/drugs/drug-approvals-and-databases/ndc-directory

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.